Camrelizumab

AbMole BioScience

Camrelizumab

9

1798286-48-2

Chemical

Research Use Only

Camrelizumab (SHR-1210) is a potent humanied high-affinity IgG4-kappa monoclonal antibody (mAb) to PD-1. Camrelizumab binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an IC50 of 0.70 nM. Camrelizumab acts as anti-PD-1/PD-L1 agent and can be used for cancer research, including NSCLC, ESCC, Hodgkin lymphoma, and advanced HCC et,al.

Please store the product under the recommended conditions in the Certificate of Analysis.

12352200